Indian stock markets saw a strong upward trend on Wednesday. The Nifty 50 and Sensex both closed higher, driven by gains in auto, FMCG, and...

Despite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

The Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...

Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...

Reliance Industries, a conglomerate with diverse interests ranging from petrochemicals to telecommunications, achieved a 52-week high of Rs...

The board of REC has approved fundraising of up to Rs 1.2 lakh crore under different debt instruments for financial year 2023-24. The funds...

Japanese multinational conglomerate Softbank Group is looking to sell shares worth Rs 600 crore in Delhivery through block deals on Wednesd...

The ₹700 crore initial public offering of pharmaceutical ingredients supplier Supriya Lifescience was subscribed 71.47 times on Monday, the...

The private sector lender sold 16,78,900 shares at an average price of Rs 16.26 apiece.

Among the stocks that touched their 52-week lows were RBL Bank, Alembic and Cox & Kings.

Domestic benchmark index NSE Nifty was trading 31.60 points up at 11,954.30.

Biosimilar drugs are follow-on biologics that have nearly the same efficacy as the original drug and used to treat cancer or autoimmune dis...

In 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...

Outcome of their performance will be known on May 16 but scores of LS aspirants are sitting on hefty returns courtesy their investments in ...

US-based private equity firm — New Silk Route Partners (NSR) — has picked up a little over 30% stake in Chandigarh-based listed pharma comp...

Reliance LifeScience on Wednesday announced the acquisition of a 74% equity stake (1.1 billion shares) in the UK-based biotech firm.